Business Context and Reporting Period
This Form 6-K filing by BiondVax Pharmaceuticals Ltd. (not Scinai Immunotherapeutics Ltd.) covers the month of January 2018. The report discloses a material corporate governance event regarding the resignation of a board member.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements.
Material Changes
On January 16, 2018, Mr. Ori Mor resigned from the Board of Directors effective immediately. Mr. Mor had served as a board member since September 2016. The resignation was attributed to personal reasons.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future operations. No specific risks or contingencies were disclosed beyond the immediate impact of the board resignation.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Mr. Mor's departure.
- Confirm whether the resignation impacts ongoing clinical trials or strategic partnerships.
- Check for any subsequent filings regarding the appointment of a replacement director.